Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential

Qun Zhang; Song Liu; Tong Li; Lin Yuan; Hansen Liu; Xueer Wang; Fuwu Wang; Shuanglian Wang; Aijun Hao; Dexiang Liu; Zhen Wang

doi:10.18632/oncotarget.11166

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential

Qun Zhang, Song Liu, Tong Li, Lin Yuan, Hansen Liu, Xueer Wang, Fuwu Wang, Shuanglian Wang, Aijun Hao, Dexiang Liu and Zhen Wang _

PDF | HTML | How to cite

Oncotarget. 2016; 7:58089-58104. https://doi.org/10.18632/oncotarget.11166

Metrics: PDF 2475 views | HTML 2993 views | ?

Abstract

Qun Zhang1, Song Liu1, Tong Li1, Lin Yuan1, Hansen Liu2, Xueer Wang1, Fuwu Wang3, Shuanglian Wang1, Aijun Hao3, Dexiang Liu2, Zhen Wang1,3

1Department of Physiology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China

2Department of Medical Psychology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China

3Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong Provincial Key Laboratory of Mental Disorders, Department of Histology and Embryology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China

Correspondence to:

Dexiang Liu, email: [email protected]

Zhen Wang, email: [email protected]

Keywords: hydrogen sulfide, bone marrow mesenchymal stem cells, transplants, brain-derived neurotrophic factor, vascular endothelial growth factor

Received: February 08, 2016 Accepted: July 27, 2016 Published: August 09, 2016

ABSTRACT

Bone marrow mesenchymal stem cells (BMSCs) transplantation has shown great promises for treating various brain diseases. However, poor viability of transplanted BMSCs in injured brain has limited the therapeutic efficiency. Hypoxia-ischemic injury is one of major mechanisms underlying the survival of transplanted BMSCs. We investigated the mechanism of preconditioning of BMSCs with hydrogen sulfide (H2S), which has been proposed as a novel therapeutic strategy for hypoxia-ischemic injury. In this study, we demonstrated that preconditioning of NaHS, a H2S donor, effectively suppressed hypoxia-ischemic-induced apoptosis whereby the rise in Bax/Bcl-2 ratio. Further analyses revealed Akt and ERK1/2 pathways were involved in the protective effects of NaHS. In addition, NaHS preconditioning increased secretion of BDNF and VEGF in BMSCs. Consistent with in vitro data, transplantation of NaHS preconditioned BMSCs in vivo further enhanced the therapeutic effects of BMSCs on neuronal injury and neurological recovery, associated with increased vessel density and upregulation of BDNF and VEGF in the ischemic tissue. These findings suggest that H2S could enhance the therapeutic effects of BMSCs. The underlying mechanisms might be due to enhanced capacity of BMSCs and upregulation of protective cytokines in the hypoxia tissue.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11166

Publication Alerts

Research Papers:

Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential

Abstract